Quantbot Technologies LP Acquires New Holdings in Kenvue Inc. $KVUE

Key Points

• Quantbot Technologies acquired 88,898 Kenvue shares worth approximately $1.7 million during the second quarter. Other institutional investors also initiated positions, and institutions now own 97.64% of KVUE’s stock.
• Kenvue reported quarterly revenue of $3.96 billion, up 3% year over year, but earnings of $0.31 per share narrowly missed analyst expectations. Shares opened at $19.41, within a 52-week range of $14.02 to $21.63.
• Kenvue is paying a quarterly dividend of $0.21 per share, equivalent to an annualized yield of about 4.3%. Analysts remain generally neutral, with an average “Hold” rating and a $19.27 price target.

Quantbot Technologies LP bought a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 88,898 shares of the company's stock, valued at approximately $1,699,000.

Several other hedge funds also recently bought and sold shares of the stock. Varma Mutual Pension Insurance Co acquired a new stake in shares of Kenvue during the second quarter valued at about $9,263,000. Westpac Banking Corp acquired a new position in shares of Kenvue in the 2nd quarter worth approximately $747,000. Korea Investment CORP purchased a new position in shares of Kenvue during the 2nd quarter worth approximately $25,931,000. EP Wealth Advisors LLC purchased a new position in shares of Kenvue during the 2nd quarter worth approximately $272,000. Finally, Heartland Bank & Trust Co purchased a new position in shares of Kenvue during the 2nd quarter worth approximately $231,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Kenvue Stock Performance

Shares of KVUE stock opened at $19.41 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $21.63. The stock has a market capitalization of $37.27 billion, a PE ratio of 22.30, a P/E/G ratio of 1.36 and a beta of 0.47. The firm has a 50 day moving average of $19.08 and a two-hundred day moving average of $18.21.

Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The business had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. During the same quarter last year, the firm earned $0.29 EPS. The business's revenue was up 3.0% on a year-over-year basis. On average, research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 4.3%. The ex-dividend date of this dividend is Wednesday, August 12th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is presently 96.55%.

Analyst Ratings Changes

KVUE has been the topic of a number of research analyst reports. Weiss Ratings raised Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, June 15th. Barclays raised their price target on Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. Wall Street Zen cut Kenvue from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. UBS Group cut their price objective on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Tuesday, August 11th. Finally, Zacks Research lowered Kenvue from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 7th. Three analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, Kenvue currently has an average rating of "Hold" and an average price target of $19.27.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source